-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The application of C5 complement inhibitors in PNH therapy has yet to be popularized PNH is a very rare acquired hematopoietic stem cell clonal disease with an incidence of less than one in 100,000 and common clinical manifestations of anemia and hemoglobinuria
Professor Wan Dingming
Professor, chief physician, master tutor, well-known expert of Henan Province
The First Affiliated Hospital of Zhengzhou University is the secretary of the Hematology Branch, the deputy director of the Department of Hematology, and the director of the Hematopoietic Stem Cell Transplantation Center
Member of the Hematopoietic Stem Cell Transplantation Application Group of the Hematology Branch of the Chinese Medical Association
Chairman of the Hematopoietic Stem Cell Transplantation Professional Committee of Henan Research Hospital Association
Chairman of the Hematology Professional Committee of Henan Gerontology and Geriatrics Society
Standing Committee Member of the Professional Committee of Precision Diagnosis and Treatment of Hematology of the Chinese Association of Research Hospitals
Member of the Transplantation and Cell Therapy Group of the Hematology and Oncology Professional Committee of the Chinese Anti-Cancer Association
Editor: Wenting Review: Professor Wan Dingming Typesetting: Wenting Execution: moly
Poke "Read the original article" to see more